Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0755
D

Medication Error: Wrong Antihistamine Administered

Glendora, California Survey Completed on 04-17-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

A deficiency occurred when a licensed vocational nurse administered cetirizine 10 mg to a resident instead of the physician-ordered loratadine 10 mg. The resident, who had diagnoses including Type 2 Diabetes Mellitus, acute osteomyelitis of the left ankle and foot, and cellulitis of the left lower limb, was admitted and readmitted to the facility with intact cognition. The physician's order specifically required loratadine 10 mg by mouth once daily for skin allergy, but during a medication pass, the nurse gave cetirizine, which was not ordered for the resident. The nurse explained that cetirizine was administered because it was the house supply provided by the pharmacy, despite the absence of a physician's order for cetirizine. The Director of Nursing confirmed that the order was for loratadine and that cetirizine should not have been given. Facility policy required medications to be administered as prescribed and for staff to verify the correct medication, dose, and resident before administration. The error resulted in a medication error and had the potential to cause adverse side effects for the resident.

Plan Of Correction

F755: Pharmacy Services/Procedure/Pharmacist/Records CORRECTIVE ACTION: On 4/17/25, Resident 27 was assessed by a licensed nurse and no adverse reaction was noted. Change of Condition for the Medication Error was initiated and MD was made aware with no new order but to continue to monitor resident. Resident was monitored for 3 consecutive days with no adverse reaction noted related to medication error. On 04/17/25, Medication Cart was supplied with Loratadine. LVN 4 is no longer working at the facility. OTHER RESIDENTS AFFECTED IDENTIFICATION All Residents had the potential to be affected by the deficient practice. On 04/17/25, an audit of all Medication Carts for availability of over-the-counter medications for residents with orders for its use was conducted. All over-the-counter medications were available and none were identified to be affected by the deficient practice. MEASURES AND SYSTEMIC CHANGES Inservice was initiated on 04/17/2025 by DON regarding proper medication administration as ordered by MD. On 04/17/2025, DON/Designee initiated a weekly medication administration observation to 2 random nurses to ensure administration of correct medication as ordered by MD. Medical record will include in the daily audit the MAR for any missed dose of medications ordered by MD. MONITORING PERFORMANCE DON/Designee will report findings from weekly medication administration observation and trends to the monthly QAA meeting for further recommendations for 3 months or until substantial compliance is met.

An unhandled error has occurred. Reload 🗙